These days there is a lot of hype surrounding the use of artificial intelligence (AI) in data-driven drug development. The advances are incredible, and wide-spread, but how much of the information is valid? It’s time to separate fact from fiction, identify some of the issues surrounding the status quo of medical technology, and outline some solutions for the future.
To begin, it’s of paramount importance to recognize humanity, and to recognize what is really at stake here, and the reason we use AI in the first place. Which is to find ways to help people by using all the science and technology at our disposal. So if people are important, if our humanity is a priority, we need a holistic understanding of the state of the industry. We are not debating the use of AI to advance science, but identifying the line between hypothesis-driven and data-driven development.
Introduction La cybersécurité est devenue une priorité stratégique pour toutes les entreprises, grandes ou petites.…
Cybersécurité : les établissements de santé renforcent leur défense grâce aux exercices de crise Face…
La transformation numérique du secteur financier n'a pas que du bon : elle augmente aussi…
L'IA : opportunité ou menace ? Les DSI de la finance s'interrogent Alors que l'intelligence…
Telegram envisage de quitter la France : le chiffrement de bout en bout au cœur…
Sécurité des identités : un pilier essentiel pour la conformité au règlement DORA dans le…
This website uses cookies.